| 05/06/2026 6:04 AM | Anavex Life Sciences (1314052) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/01/2026 6:18 PM | Anavex Life Sciences (1314052) Issuer Paeger Axel (2131180) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/26/2026 2:45 PM | Anavex Life Sciences (1314052) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/25/2026 3:06 PM | Anavex Life Sciences (1314052) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/25/2026 5:07 AM | Anavex Life Sciences (1314052) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/09/2026 3:40 PM | Anavex Life Sciences (1314052) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 02/09/2026 6:31 AM | Anavex Life Sciences (1314052) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 4:26 PM | Anavex Life Sciences (1314052) Issuer Boenisch Sandra (1655366) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 4:27 PM | Anavex Life Sciences (1314052) Issuer MISSLING CHRISTOPHER U (1196573) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 6:30 AM | Anavex Life Sciences (1314052) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 6:42 AM | Anavex Life Sciences (1314052) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/03/2025 7:41 PM | Anavex Life Sciences (1314052) Issuer MISSLING CHRISTOPHER U (1196573) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/03/2025 7:42 PM | Anavex Life Sciences (1314052) Issuer Boenisch Sandra (1655366) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/12/2025 6:00 PM | Anavex Life Sciences (1314052) Issuer MISSLING CHRISTOPHER U (1196573) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/22/2025 4:30 PM | Anavex Life Sciences (1314052) Issuer MISSLING CHRISTOPHER U (1196573) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/22/2025 4:30 PM | Anavex Life Sciences (1314052) Issuer Boenisch Sandra (1655366) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/23/2025 11:15 PM | Anavex Life Sciences (1314052) Filer | Form EFFECT | |
| 07/14/2025 3:30 PM | Anavex Life Sciences (1314052) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 07/03/2025 4:25 PM | Anavex Life Sciences (1314052) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/13/2025 4:30 PM | Anavex Life Sciences (1314052) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/09/2025 4:30 PM | Anavex Life Sciences (1314052) Issuer Thomas Steffen (1646396) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |